Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
Hanyang University Institute for Rheumatology Research, Seoul, Korea.
J Korean Med Sci. 2021 Oct 25;36(41):e263. doi: 10.3346/jkms.2021.36.e263.
To evaluate the incidence of fractures and fracture risk factors in Korean patients with polymyalgia rheumatica (PMR).
All PMR patients who visited a rheumatology clinic at a tertiary referral hospital between March 2005 and March 2018 were retrospectively assessed. We estimated bone mineral density (BMD) screening rate within 6 months of the first visit and classified the patients according to the performance and results of BMD screening. Incidence rates (IRs) of fractures were calculated in each group and risk factors for fractures were identified using Poisson regression analysis.
A total of 95 PMR patients with median (interquartile range) age of 64.0 (56.0-72.0) years were included. Baseline BMD was assessed in only 55.8% of these patients (n = 53); 24 patients with osteoporosis, 20 with osteopenia, and 9 with normal BMD. During 433.1 person-years (PYs) of observation, 17 fractures occurred in 12 patients (IR, 3.93 [95% confidence interval (CI), 2.46-6.26]/100 PYs); 8.32 (95% CI, 4.09-16.90)/100 PYs in the osteopenia group, 3.40 (95% CI, 1.30-8.90)/100 PYs in the osteoporosis group, and 3.37 (95% CI, 1.53-7.39)/100 PYs in the no BMD test group. Risk factors for fractures were female sex, advanced age (≥ 65 years), longer follow-up duration, initial glucocorticoid dose ≥ 10 mg/day, and higher cumulative glucocorticoid dose over the first 6 months.
The incidence rate of fractures in Korean patients with PMR was 3.93/100 PYs. Female sex, advanced age, longer follow-up duration, and increased glucocorticoid dose are risk factors for osteoporotic fracture.
评估韩国多发性肌痛症(PMR)患者骨折的发生率和骨折的危险因素。
回顾性评估 2005 年 3 月至 2018 年 3 月期间在一家三级转诊医院风湿病科就诊的所有 PMR 患者。我们评估了首次就诊后 6 个月内进行骨密度(BMD)筛查的比例,并根据 BMD 筛查的表现和结果对患者进行分类。计算了每组的骨折发生率(IR),并使用泊松回归分析确定骨折的危险因素。
共纳入 95 例 PMR 患者,中位(四分位间距)年龄为 64.0(56.0-72.0)岁。仅对其中 55.8%的患者(n=53)进行了基线 BMD 评估;24 例骨质疏松症患者,20 例骨量减少患者,9 例 BMD 正常患者。在 433.1 人年(PY)的观察期间,12 例患者发生了 17 例骨折(IR,3.93[95%置信区间(CI),2.46-6.26]/100 PYs);骨量减少组为 8.32(95%CI,4.09-16.90)/100 PYs,骨质疏松组为 3.40(95%CI,1.30-8.90)/100 PYs,无 BMD 检测组为 3.37(95%CI,1.53-7.39)/100 PYs。骨折的危险因素是女性、年龄较大(≥65 岁)、随访时间较长、初始糖皮质激素剂量≥10mg/天和前 6 个月内累积糖皮质激素剂量较高。
韩国 PMR 患者骨折的发生率为 3.93/100 PYs。女性、年龄较大、随访时间较长和糖皮质激素剂量增加是骨质疏松性骨折的危险因素。